Similar Papers

Paper Title
Journal
Date
Author
Obese and insulin resistant JCR:LA‐cp rats fed eicosapentaenoic acid and docosahexaenoic acid have higher IL‐2 and lower TNF‐α production
-
The FASEB Journal | VOL. 22
--
01 Mar 2008
Irbesartan-mediated reduction of renal and cardiac damage in insulin resistant JCR : LA-cp rats
Jc Russell ... Df Vine
British Journal of Pharmacology | VOL. 158
Jc Russell, et. al.Jc Russell ... Df Vine
08 Oct 2009
Trans-11 Vaccenic Acid Dietary Supplementation Induces Hypolipidemic Effects in JCR:LA-cp Rats
Ye Wang ... Spencer D Proctor
The Journal of Nutrition | VOL. 138
Ye Wang, et. al.Ye Wang ... Spencer D Proctor
01 Nov 2008
Modulation of vasomotion in resistance arteries of JCR:LA-cp rats: a model of insulin resistance
Sheila F O'Brien ... James C Russell
Canadian Journal of Physiology and Pharmacology | VOL. 77
Sheila F O'Brien, et. al.Sheila F O'Brien ... James C Russell
01 Jan 1998
View more papers

More From: Atherosclerosis Supplements

Paper Title
Journal
Date
Author
Similarities and differences between European and American guidelines on the management of blood lipids to reduce cardiovascular risk
Lale Tokgözoğlu ... Alberico L Catapano
Atherosclerosis Supplements | VOL. 42
Lale Tokgözoğlu, et. al.Lale Tokgözoğlu ... Alberico L Catapano
01 Dec 2020
How registers could enhance knowledge and characterization of genetic dyslipidaemias: The experience of the LIPIGEN in Italy and of other networks for familial hypercholesterolemia
Marta Gazzotti ... Alberico L Catapano
Atherosclerosis Supplements | VOL. 42
Marta Gazzotti, et. al.Marta Gazzotti ... Alberico L Catapano
01 Dec 2020
Lipid-lowering therapy and low-density lipoprotein cholesterol goal achievement in patients with acute coronary syndromes: The ACS patient pathway project
Ulf Landmesser ... Alberico L Catapano
Atherosclerosis Supplements | VOL. 42
Ulf Landmesser, et. al.Ulf Landmesser ... Alberico L Catapano
01 Dec 2020
Title page
-
Atherosclerosis Supplements | VOL. 42
--
01 Dec 2020
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.